BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 270 found
  Current Search:  bone: 4477, metabolic: 270     

HTML
63%
Metabolic syndrome associated with subclinical CVD
Atherosclerosis 2010; Advance online publication MedWire News: People with the metabolic syndrome (MS) are at increased risk for asymptomatic cardiovascular disease (CVD), a community-based study has found.

But the significance of this finding is debatable,...

MedWire News:  Mar 12 2010 8:46PM
Matching: metabolic
Find similar documents
HTML
63%
Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycoly
Search for this author in: Sunil A Sheth1, 2, 3, 7 Search for this author in: Roland Nilsson1, 2, 3 Search for this author in: Andrew P Wojtovich4, 5 Search for this author in: Jeong Hyun Lee6 Search for this author in: Fabiana Perocchi1, 2, 3 Search for this...
Nature:  Mar 12 2010 6:10PM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
- Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have...
Pharma Live:  Mar 12 2010 4:51PM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license...
Therapeutics Daily:  Mar 12 2010 2:20PM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Let the jobs come to you!

Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases,...

PharmiWeb:  Mar 12 2010 1:34PM
Matching: metabolic
Find similar documents
HTML
63%
The Metabolic Syndrome in Systemic Lupus Erythematosus
Parker B et al.

Systemic lupus erythematosus (SLE) is associated with an increased prevalence of the MetS and patients also show evidence of increased insulin resistance.

Controversy remains, however, regarding the precise definition of the MetS and its...

MDLinx:  Mar 12 2010 12:04PM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license...
SmartBrief:  Mar 12 2010 11:49AM
Matching: metabolic
Find similar documents
HTML
63%
Angeion Corporation Partners with Team Garmin-Transitions
SAINT PAUL, Minn.-- (BUSINESS WIRE) -- Angeion Corporation (NASDAQ: ANGN) today announced that it has entered into an agreement to serve as the official supplier of metabolic and endurance training systems for Team Garmin-Transitions, the American professional...
SmartBrief:  Mar 12 2010 11:40AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen, Rhythm Sign License Agreement For Programs In Metabolic Disorders
Ipsen, a global biotechnology specialty care group and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, have concluded a license agreement for Ipsens proprietary peptide therapeutics targeting...
Pharmaceutical Business Review:  Mar 12 2010 11:34AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
PARIS & BOSTON - (BUSINESS WIRE) - Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic...
NewsBlaze:  Mar 12 2010 10:15AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have...
Genetic Engineering News:  Mar 12 2010 9:07AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Companies mentioned in this article: Ipsen PARIS & BOSTON -- (BUSINESS WIRE) -- Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company...
Freshnews.com:  Mar 12 2010 9:07AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have...
Genetic Engineering News:  Mar 12 2010 9:07AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Companies mentioned in this article: Ipsen PARIS & BOSTON -- (BUSINESS WIRE) -- Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company...
Freshnews.com:  Mar 12 2010 9:07AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Regulatory News: Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have...
Genetic Engineering News:  Mar 12 2010 8:13AM
Matching: metabolic
Find similar documents
HTML
63%
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Ipsen (Paris: IPN.PA) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group, and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a...
Yahoo! Canada:  Mar 12 2010 7:50AM
Matching: metabolic
Find similar documents
HTML
63%
Associations of the 344 T>C and the 3097 G>A Polymorphisms of CYP11B2 Gene With Hypertension, Type 2 Diabetes, and Metabolic Syndrome in a French Population
Associations of the 344 T>C and the 3097 G>A Polymorphisms of CYP11B2 Gene With Hypertension, Type 2 Diabetes, and Metabolic Syndrome in a French Population American Journal of Hypertension advance online publication, March 11, 2010.

doi:10.1038...

American Journal of Hypertension:  Mar 11 2010 5:37PM
Matching: metabolic
Find similar documents
HTML
63%
Technological Advances in Sports Medicine
With different sports finally gaining the desired recognition in India and people getting increasingly concerned about their health and fitness quotient, the sports medicine speciality also seem to have dropped the veil of anonymity.

The Government of India...

Express Healthcare Management:  Mar 11 2010 1:26PM
Matching: metabolic
Find similar documents
HTML
63%
Quetiapine Linked to More Rapid Onset of Metabolic Disturbances in Elderly Patients
_ Quetiapine Linked to More Rapid Onset of Metabolic Disturbances in Elderly Patients.
Abstracts in Hematology and Oncology:  Mar 11 2010 11:48AM
Matching: metabolic
Find similar documents
HTML
63%
Components of Metabolic Syndrome Linked to Plaque Progression
_ Components of Metabolic Syndrome Linked to Plaque Progression.
Abstracts in Hematology and Oncology:  Mar 11 2010 11:48AM
Matching: metabolic
Find similar documents
HTML
63%
Dietary Intakes of Fiber and Magnesium and Incidence of Metabolic Syndrome in First Year After Renal Transplantation
Noori N et al.

Dietary Intakes of Fiber and Magnesium and Incidence of Metabolic Syndrome in First Year After Renal Transplantation.

MDLinx:  Mar 11 2010 11:20AM
Matching: metabolic
Find similar documents
HTML
63%
Life Sciences: RTI International reports research in life sciences
Today's Medical & Research News Life Sciences RTI International reports research in life sciences March 11th, 2010 Printer-Friendly Version State:NC Country:United States Life Sciences Applied Toxicology Metabolism Data detailed in 'Metabolomics in the...
NewsRX:  Mar 11 2010 9:52AM
Matching: metabolic
Find similar documents
HTML
63%
RTI International reports research in life sciences
Data detailed in 'Metabolomics in the assessment of chemical-induced reproductive and developmental outcomes using non-invasive biological fluids: application to the study of butylbenzyl phthalate' have been presented.

'This study was conducted to evaluate...

NewsRX:  Mar 11 2010 7:11AM
Matching: metabolic
Find similar documents
HTML
63%
Medical News: ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research
ZenBio announce that they will be a commercial source for the popular murine 3T3-L1 cell line, which has been fundamental in metabolic disease research for 30 years.

Originally derived from Swiss mouse embryo tissue by Dr.

Medical News: ZenBio Licenses An...

BioFind:  Mar 11 2010 3:41AM
Matching: metabolic
Find similar documents
HTML
63%
TopAbstracts in Erectile Dysfunction 03/09/2010
All Webcasts / CME All Cases Congress Resource Centre All Medical Resources My Personal Edition Warning| Privacy Recent news - Erectile Dysfunction TopAbstracts in Erectile Dysfunction 02/09/2010- (DGNews) TopAbstracts in Erectile Dysfunction 01/12/2010- ...
Doctors Guide:  Mar 11 2010 2:49AM
Matching: metabolic
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.